Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma (Q42138461)
Jump to navigation
Jump to search
scientific article published on August 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma |
scientific article published on August 2015 |
Statements
1 reference
Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma (English)
1 reference
Phoebe Starr
1 reference
1 August 2015
1 reference
1 reference
Spec Issue
1 reference
Identifiers
1 reference
1 reference